Free Trial
NASDAQ:ULBI

Ultralife Q3 2026 Earnings Results & Report

Ultralife logo
$15.74 -0.05 (-0.29%)
As of 12:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Ultralife missed analyst expectations on both earnings and revenue in its Q3 2026 results, released November 6, 2026. The company reported EPS of $0.14 versus the $0.23 consensus estimate, while revenue of $48.27 million fell short of the $56 million estimate by $7.73 million.

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
After Market Closes
Conference Call Date
Conference Call
4:00 PM ET

Ultralife EPS Results

Actual EPS
$0.14
Consensus EPS
$0.23
Beat/Miss
Missed by -$0.09
One Year Ago EPS
N/A
EPS Beat Rate
0 of last 8 quarters

Ultralife Revenue Results

Actual Revenue
$48.27 million
Expected Revenue
$56 million
Beat/Miss
Missed by -$7.73 million
YoY Revenue Growth
N/A

Ultralife Q3 2026 Earnings FAQ

Ultralife (NASDAQ:ULBI) reported earnings of $0.14 per share for Q3 2026, missing the consensus estimate of $0.23. The report was announced on Friday, November 6, 2026.

Ultralife reported revenue of $48.27 million for Q3 2026, against a consensus estimate of $56 million.

Ultralife Earnings Headlines

Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a race among SpaceX, Blue Origin, and others to build massive satellite constellations. One tiny firm holds the patented tech required to transmit satellite data to Earth at scale - and it reportedly powers SpaceX's most profitable division. Shares trade for under 5 dollars. Former JPMorgan wealth manager Ross Givens says it's the most uniquely positioned stock he's seen in 20 years of trading.tc pixel
Ultralife Corporation Reports Third Quarter Results
See More Ultralife Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ultralife? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ultralife and other key companies, straight to your email.

About Ultralife

Ultralife (NASDAQ:ULBI) is a New York-based manufacturer of power and communications products serving government, defense, aerospace, industrial, medical and other specialized markets. The company develops and produces batteries, battery packs, chargers and related power-management products designed for portable and mission-critical equipment.

Ultralife’s product portfolio includes lithium primary and rechargeable batteries, custom battery assemblies, military battery systems, charging equipment and accessories. Its communications business provides products such as radio and communications accessories, amplifiers, adapters and related equipment used in field and tactical applications.

Founded in 1990, Ultralife sells its products through direct sales, distributors and original equipment manufacturers in the United States and international markets. The company is led by Michael D. Popielec, who serves as president and chief executive officer.

View Ultralife Profile